Back to Results
First PageMeta Content
Immunology / Biology / Autoimmune diseases / Alemtuzumab / Genzyme / Interferon beta-1a / Interferon / Therapies under investigation for multiple sclerosis / Treatment of multiple sclerosis / Multiple sclerosis / Cytokines / Immune system


PRESS RELEASE At Four Years, Treatment Effect Maintained in More Than Two-Thirds of Patients Who Received Genzyme’s Lemtrada in Pivotal Studies - In approximately 70 percent of patients, disability scores improved or
Add to Reading List

Document Date: 2014-10-09 14:57:39

Open Document

File Size: 94,94 KB

Share Result on Facebook

City

Boston / New York / Paris / /

Company

Bayer / Genzyme Corporation / Sanofi Company / EMD Serono Inc. / /

Country

Guatemala / Mexico / Chile / United States / Brazil / Canada / Australia / Argentina / /

Event

FDA Phase / Company Listing Change / /

Facility

University of Cambridge / /

IndustryTerm

pharmaceutical / healthcare / therapeutic solutions / consumer healthcare / diabetes solutions / /

MedicalCondition

MS disease / rare and debilitating diseases / rare diseases / headache / inflammatory process / thyroid disease / nausea / thrombocytopenia / serious infections / fatigue / multiple sclerosis / glomerulonephritis / diarrhea / MS / pruritus / infections / sepsis / reduced disease / autoimmune disorders / insomnia / disease / pivotal multiple sclerosis / chills / immune thrombocytopenia / diabetes / active disease / thyroid disorders / urticaria / dizziness / rash / /

MedicalTreatment

intravenous infusion / /

Organization

Treatment in Multiple Sclerosis / European Committee for Research and Treatment / Department of Clinical Neurosciences / University of Cambridge / U.S. Food and Drug Administration / European Union / /

Person

David Meeker / Alasdair Coles / /

Position

global healthcare leader / President and CEO / Lecturer / /

Product

LemtradaTM / Rebif / European Union / Lemtrada / Lemtrada™ (alemtuzumab) / United States / /

ProvinceOrState

Mississippi / /

Technology

therapeutic solutions / /

URL

www.genzyme.com / /

SocialTag